ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Sagent Pharmaceuticals INC

Official 2024 U.S. DOL Form 5500 summary for Sagent Pharmaceuticals INC (Sagent Pharmaceuticals INC 401k Plan · EIN 20-5522946 · PN 001): $30.15M net assets, 119 active participants, and $22.57 per $10,000 (22.57 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSagent Pharmaceuticals INC
Filing IdentifierSagent Pharmaceuticals INC 401k Plan · EIN 20-5522946 · PN 001
Plan Category & State401(k) Defined Contribution (IL)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$30.15M
Active Participants119
Direct Admin Fee Rate$22.57 per $10,000 (22.57 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderSageView Advisory Group
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI